Epigenetic modulators as therapeutic targets in prostate cancerInês Graça, Cármen Jerónimo|Clinical Epigenetics|2016Cited by 90
Anti-neoplastic properties of hydralazine in prostate cancerInês Graça, Cármen Jerónimo|Oncotarget|2014Cited by 63